Authors
Loading...
Animal study shows CTGF monoclonal antibody therapy limits fibrosis and boosts survival in mice after myocardial infarction, suggesting a novel target for post-infarct repair.
Vainio et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: